


EU Approves Certolizumab Pegol for Pregnant & Nursing Patients

High Cost of Rheumatoid Arthritis Medications Burdens Patients in Saudi Arabia

Certolizumab Pegol Promising for Plaque Psoriasis in Phase 3 Trial

Certolizumab Pegol Usage Compatible with Breastfeeding
Transfer of Certolizumab in Breast Milk Not a Concern

New RA Therapy Promising in Clinical Trial

Certolizumab Pegol Combination Therapy Better than Methotrexate Monotherapy in DMARD-Naive Patients with RA
Certolizumab Combo Helps Curb RA Damage
